Viewing StudyNCT05494580



Ignite Creation Date: 2024-05-06 @ 5:58 PM
Last Modification Date: 2024-10-26 @ 2:39 PM
Study NCT ID: NCT05494580
Status: RECRUITING
Last Update Posted: 2023-04-11
First Post: 2022-07-26

Brief Title: Pamiparib Plus Surufatinib in Patients With Platinum-resistant Ovarian Cancer
Sponsor: Sun Yat-sen University
Organization: Sun Yat-sen University

Conditions & Keywords Data

Conditions:
Name
Primary Peritoneal Cancer
Ovarian Cancer
Ovarian Carcinoma
Platinum-resistant Ovarian Cancer
Fallopian Tube Carcinosarcoma
Keywords:
Name View
Platinum-resistant View
Ovarian cancer View
PARP inhibitor View
Antiangiogenic agents View